Barclays
VIVE

Barclays’s VIVEVE MED INC VIVE Stock Holding History

Barclays’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-269
Closed – – 5423
2022
Q1 		$0 Buy
+269
New +$269 ﹤0.01% 5791
2019
Q3 		– Sell
-2
Closed -$1K – 7290
2019
Q2 		$1K Hold
2
– – ﹤0.01% 6870
2019
Q1 		$2K Hold
2
– – ﹤0.01% 6880
2018
Q4 		$2K Hold
2
– – ﹤0.01% 6754
2018
Q3 		$7K Sell
2
-24
-92% -$68K ﹤0.01% 6738
2018
Q2 		$71K Buy
26
+22
+550% +$63.4K ﹤0.01% 5457
2018
Q1 		$16K Buy
4
+1
+33% +$4.35K ﹤0.01% 6513
2017
Q4 		$14K Buy
+3
New +$15.6K ﹤0.01% 6430
2017
Q3 		– Hold
0
– – – 6620
2017
Q2 		– Hold
0
– – – 6458

Other funds holding VIVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Barclays's VIVE Position: Q2 2022 in Review

Barclays sold out of VIVEVE MED INC (VIVE) in Q2 2022, closing a stake of 269 shares.

Barclays first reported a position in VIVE in Q4 2017 and held it in 8 quarters. The position peaked at $71K in Q2 2018. 20 funds tracked by Wall St. Rank hold VIVE as of Q2 2022.

  • Barclays reported no remaining VIVEVE MED INC position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 269 VIVEVE MED INC shares in Q2 2022.
  • Barclays first reported a position in VIVEVE MED INC in Q4 2017 and held it in 8 quarters.
  • Barclays's VIVEVE MED INC position peaked at $71K in Q2 2018.
  • 20 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.